ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1

CUSIP: 29664WAB1

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Debt / NOTE 4.000%11/1
Market price (% of par)
52.0%
Total 13F principal
$192,120,851
Principal change
-$6,178,500
Total reported market value
$110,572,628
Number of holders
17
Value change
-$4,399,266
Number of buys
4
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 29664WAB1?
CUSIP 29664WAB1 identifies 29664WAB1 - ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 as of Q3 2023

As of 30 Sep 2023, ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 was held by 17 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $192,120,851 in principal (par value) of the bond. The largest 10 bondholders included Pentwater Capital Management LP, Davidson Kempner Capital Management LP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, TENOR CAPITAL MANAGEMENT Co., L.P., Two Seas Capital LP, WHITEBOX ADVISORS LLC, AMERIPRISE FINANCIAL INC, SILVERBACK ASSET MANAGEMENT LLC, READYSTATE ASSET MANAGEMENT LP, and DCF Advisers, LLC. This page lists 17 institutional bondholders reporting positions for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.